Let there be bio-pharma deals, says trade group chief
Posted on November 20, 2008 at 4:23 PM
Filed under: Best Practices | CD Community | Corporate Strategy | Deal International | Election 2008 | Joint Ventures and Alliances | People | Q&A | Trends
Tagged: Barack Obama , Biotechnology Industry Organization , Bristol-Myers , GlaxoSmithKline , James Greenwood , Merck & Co. , Pfizer , Schering-Plough , Wyeth
Filed under: Best Practices | CD Community | Corporate Strategy | Deal International | Election 2008 | Joint Ventures and Alliances | People | Q&A | Trends
Tagged: Barack Obama , Biotechnology Industry Organization , Bristol-Myers , GlaxoSmithKline , James Greenwood , Merck & Co. , Pfizer , Schering-Plough , Wyeth
Big Pharmas are cutting costs; Bristol-Myers Squibb Co., Wyeth, Pfizer, Merck & Co., Schering-Plough Corp. and GlaxoSmithKline plc have all announced reductions in their U.S. sales forces. They're also worrying about life under the Democrats.Do they still want to replenish their pipelines with high-priced biotech drugs? James Greenwood, president and... Continue reading























And the winners are...



